[1]
|
吕经纬. 保乳术与改良根治术治疗乳腺癌的效果及对患者生活质量的影响分析[J]. 中国实用医药, 2021, 16(31): 80-82.
|
[2]
|
Bremnes, R.M., Dønnem, T., Al-Saad, S., et al. (2011) The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer. Journal of Thoracic Oncology, 6, 209-217. https://doi.org/10.1097/JTO.0b013e3181f8a1bd
|
[3]
|
Mishalian, I., Granot, Z. and Fridlender, Z.G. (2017) The Diversity of Circulating Neutrophils in Cancer. Immunobiology, 222, 82-88. https://doi.org/10.1016/j.imbio.2016.02.001
|
[4]
|
张哲源, 刘怡文, 付臻, 等. 炎症和肿瘤微环境与食管癌防治研究进展食管疾病[J]. 食管疾病, 2022, 4(2): 85-90.
|
[5]
|
Jézéquel, P., Kerdraon, O., Hondermarck, H., et al. (2019) Identification of Three Subtypes of Triple-Negative Breast Cancer with Potential Therapeutic Implications. Breast Cancer Research, 21, Article No. 65.
https://doi.org/10.1186/s13058-019-1148-6
|
[6]
|
Pollard, J.W. (2004) Tumour-Educated Macrophages Promote Tumour Progression and Metastasis. Nature Reviews Cancer, 4, 71-78. https://doi.org/10.1038/nrc1256
|
[7]
|
Yan, X., Li, F., Wang, X., et al. (2020) Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Patients with Coronavirus Disease 2019: A Retrospective Cross-Sectional Study. Journal of Medical Virology, 92, 2573-2581.
https://doi.org/10.1002/jmv.26061
|
[8]
|
Yan, M., Lesyk, G., Radziwon-Balicka, A. and Jurasz, P. (2014) Pharma-cological Regulation of Platelet Factors That Influence Tumor Angiogenesis. Seminars in Oncology, 41, 370-377.
https://doi.org/10.1053/j.seminoncol.2014.04.007
|
[9]
|
Chen, K.-J., Zhou, L., Xie, H.-Y.., et al. (2012) Intratumoral Regulatory T Cells Alone or in Combination with Cytotoxic T Cells Predict Prognosis of Hepatocellular Carcinoma after Resection. Medical Oncology, 29, 1817-1826.
https://doi.org/10.1007/s12032-011-0006-x
|
[10]
|
Denkert, C., Loibl, S., Noske, A., et al. (2010) Tumor-Associated Lymphocytes as an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer. Journal of Clin-ical Oncology, 28, 105-113.
https://doi.org/10.1200/JCO.2009.23.7370
|
[11]
|
Cortazar, P. and Geyer Jr., CE. (2015) Pathological Complete Re-sponse in Neoadjuvant Treatment of Breast Cancer. Annals of Surgical Oncology, 22, 1441-1446. https://doi.org/10.1245/s10434-015-4404-8
|
[12]
|
Cortazar, P., Zhang, L., Untch, M., et al. (2014) Pathological Complete Response and Long-Term Clinical Benefit in Breast Cancer: The CTNeoBC Pooled Analysis. Lancet, 384, 164-172.
https://doi.org/10.1016/S0140-6736(13)62422-8
|
[13]
|
Suppan, C., Bjelic-Radisic, V., La Garde, M., et al. (2015) Neutrophil/Lymphocyte Ratio Has No Predictive or Prognostic Value in Breast Cancer Patients Undergoing Preoperative Systemic Therapy. BMC Cancer, 15, Article No. 1027. https://doi.org/10.1186/s12885-015-2005-3
|
[14]
|
Chen, Y., Chen, K., Xiao, X., et al. (2016) Pretreatment Neutrophil-to-Lymphocyte Ratio Is Correlated with Response to Neoadju-vant Chemotherapy as an Independent Prognostic Indicator in Breast Cancer Patients: A Retrospective Study. BMC Can-cer, 16, Article No. 320. https://doi.org/10.1186/s12885-016-2352-8
|
[15]
|
Marín Hernández, C., Piñero Madrona, A., Gil Vázquez, P.J., et al. (2018) Usefulness of Lymphocyte-to-Monocyte, Neutrophil-to-Monocyte and Neutro-phil-to-Lymphocyte Ratios as Prognostic Markers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Clinical and Translational Oncology, 20, 476-483.
https://doi.org/10.1007/s12094-017-1732-0
|
[16]
|
Graziano, V., Grassadonia, A., Iezzi, L., et al. (2019) Combina-tion of Peripheral Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Is Predictive of Pathological Com-plete Response after Neoadjuvant Chemotherapy in Breast Cancer Patients. Breast, 44, 33-38. https://doi.org/10.1016/j.breast.2018.12.014
|
[17]
|
Qian, Y., Tao, J., Li, X., et al. (2018) Peripheral Inflamma-tion/Immune Indicators of Chemosensitivity and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemo-therapy. OncoTargets and Therapy, 11, 1423-1432.
https://doi.org/10.2147/OTT.S148496
|
[18]
|
Losada, B., Guerra, J.A., Malón, D., et al. (2019) Pretreatment Neu-trophil/Lymphocyte, Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutrophil/Monocyte Ratios and Outcome in El-derly Breast Cancer Patients. Clinical and Translational Oncology, 21, 855-863. https://doi.org/10.1007/s12094-018-1999-9
|
[19]
|
Wculek, S. and Malanchi, I. (2015) Neutrophils Support Lung Colonization of Metastasis-Initiating Breast Cancer Cells. Nature, 528, 413-417. https://doi.org/10.1038/nature16140
|
[20]
|
Zhang, X. and Xu, W. (2017) Neutrophils Diminish T-Cell Immunity to Foster Gastric Cancer Progression: The Role of GM-CSF/PD-L1/PD-1 Signalling Pathway. Gut, 66, 1878-1880. https://doi.org/10.1136/gutjnl-2017-313923
|
[21]
|
Zhang, X., Zhang, W., Yuan, X., et al. (2016) Neutrophils in Cancer Development and Progression: Roles, Mechanisms, and Implications (Review). International Journal of Oncolo-gy, 49, 857-867.
https://doi.org/10.3892/ijo.2016.3616
|
[22]
|
Mouchemore, K.A., Anderson, R.L. and Hamilton, J.A. (2018) Neu-trophils, G-CSF and Their Contribution to Breast Cancer Metastasis. The FEBS Journal, 285, 665-679. https://doi.org/10.1111/febs.14206
|
[23]
|
Koh, Y.W., Lee, H.J., Ahn, J.-H., Lee, J.W. and Gong, G. (2014) Prog-nostic Significance of the Ratio of Absolute Neutrophil to Lymphocyte Counts for Breast Cancer Patients with ER/PR-Positivity and HER2-Negativity in Neoadjuvant Setting. Tumour Biology, 35, 9823-9830. https://doi.org/10.1007/s13277-014-2282-5
|
[24]
|
Stoiber, D. and Assinger, A. (2020) Platelet-Leukocyte Interplay in Cancer Development and Progression. Cells, 9, Article No. 855. https://doi.org/10.3390/cells9040855
|
[25]
|
Leblanc, R., Lee, S.C., David, M., et al. (2014) Interaction Of Plate-let-Derived Autotaxin with Tumor Integrin αVβ3 Controls Metastasis of Breast Cancer Cells to Bone. Blood, 124, 3141-3150.
https://doi.org/10.1182/blood-2014-04-568683
|
[26]
|
Kang, D.W. and Min, D.S. (2010) Platelet Derived Growth Factor Increases Phospholipase D1 but Not Phospholipase D2 Expression via NFκB Signaling Pathway and Enhances Invasion of Breast Cancer Cells. Cancer Letters, 294, 125-133. https://doi.org/10.1016/j.canlet.2010.01.031
|
[27]
|
Zuo, X.-X., Yang, Y., Zhang, Y., et al. (2019) Platelets Promote Breast Cancer Cell MCF-7 Metastasis by Direct Interaction: Surface Integrin α2β1-Contacting-Mediated Activation of Wnt-β-Catenin Pathway. Cell Communication and Signaling, 17, Article No. 142. https://doi.org/10.1186/s12964-019-0464-x
|
[28]
|
Lal, I., Dittus, K. and Holmes, C.E. (2013) Platelets, Coagulation and Fibrinolysis in Breast Cancer Progression. Breast Cancer Research, 15, Article No. 207. https://doi.org/10.1186/bcr3425
|
[29]
|
Elaskalani, O., Berndt, M.C., Falasca, M. and Metharom, P. (2017) Targeting Platelets for the Treatment of Cancer. Cancers, 9, Article No. 94. https://doi.org/10.3390/cancers9070094
|
[30]
|
Felding-Habermann, B. (2003) Targeting Tumor Cell-Platelet Interac-tion in Breast Cancer Metastasis. Pathophysiology of Haemostasis and Thrombosis, 33, 56-58. https://doi.org/10.1159/000073295
|
[31]
|
Ethier, J.L., Desautels, D., Templeton, A., Shah, S. and Amir, E. (2017) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Breast Cancer: A Systematic Review and Meta-Analysis. Breast Cancer Research, 19, Article No. 2.
https://doi.org/10.1186/s13058-016-0794-1
|
[32]
|
Azab, B., Bhatt, V.R., Phookan, J., et al. (2012) Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients. Annals of Sur-gical Oncology, 19, 217-224.
https://doi.org/10.1245/s10434-011-1814-0
|
[33]
|
Azab, B., Shah, N., Radbel, J., et al. (2013) Pretreatment Neutro-phil/Lymphocyte Ratio Is Superior to Platelet/Lymphocyte Ratio as a Predictor of Long-Term Mortality in Breast Cancer Patients. Medical Oncology, 30, Article No. 432. https://doi.org/10.1007/s12032-012-0432-4
|
[34]
|
Hurt, B., Schu-lick, R., Edil, B., et al. (2017) Cancer-Promoting Mechanisms of Tumor-Associated Neutrophils. American Journal of Surgery, 214, 938-944. https://doi.org/10.1016/j.amjsurg.2017.08.003
|
[35]
|
Snoderly, H.T., Boone, B.A. and Bennewitz, M.F. (2019) Neutrophil Extracellular Traps in Breast Cancer and Beyond: Current Perspectives on Net Stim-uli, Thrombosis and Metastasis, and Clinical Utility for Diagnosis and Treatment. Breast Cancer Research, 21, Article No. 145. https://doi.org/10.1186/s13058-019-1237-6
|
[36]
|
Patel, D.A., Xi, J., Luo, J., et al. (2019) Neutro-phil-to-Lymphocyte Ratio as a Predictor of Survival in Patients with Triple-Negative Breast Cancer. Breast Cancer Re-search and Treatment, 174, 443-452.
https://doi.org/10.1007/s10549-018-05106-7
|
[37]
|
Faria, S.S., Fernandes Jr., P.C., Silva, M.J., et al. (2016) The Neutrophil-to-Lymphocyte Ratio: A Narrative Review. Ecancermedicalscience, 10, Article No. 702. https://doi.org/10.3332/ecancer.2016.702
|
[38]
|
Kim, I.S., Gao, Y., Welte, T., et al. (2019) Immuno-Subtyping of Breast Cancer Reveals Distinct Myeloid Cell Profiles and Immunotherapy Resistance Mechanisms. Nature Cell Biology, 21, 1113-1126.
https://doi.org/10.1038/s41556-019-0373-7
|
[39]
|
Mohme, M., Riethdorf, S. and Pantel, K. (2017) Circulating and Disseminated Tumour Cells—Mechanisms of Immune Surveillance and Escape. Nature Reviews Clinical Oncology, 14, 155-167.
https://doi.org/10.1038/nrclinonc.2016.144
|
[40]
|
Zhu, J., Powis de Tenbossche, C.G., Cané, S., et al. (2017) Re-sistance to Cancer Immunotherapy Mediated by Apoptosis of Tumor-Infiltrating Lymphocytes. Nature Communications, 8, Article No. 1404.
https://doi.org/10.1038/s41467-017-00784-1
|
[41]
|
de Visser, K.E., Eichten, A. & Coussens, L.M. (2006) Paradox-ical Roles of the Immune System during Cancer Development. Nature Reviews Cancer, 6, 24-37. https://doi.org/10.1038/nrc1782
|
[42]
|
Hanahan, D. and Weinberg, R.A. (2000) The Hallmarks of Cancer. Cell, 100, 57-70.
https://doi.org/10.1016/S0092-8674(00)81683-9
|
[43]
|
Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444.
https://doi.org/10.1038/nature07205
|
[44]
|
Diakos, C.I., Charles, K.A., McMillan, D.C. and Clarke, S.J. (2014) Cancer-Related Inflammation and Treatment Effectiveness. The Lancet Oncology, 15, e493-e503. https://doi.org/10.1016/S1470-2045(14)70263-3
|
[45]
|
Mego, M., Gao, H., Cohen, E.N., et al. (2016) Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer. Journal of Cancer, 7, 1095-1104.
https://doi.org/10.7150/jca.13098
|
[46]
|
Koh, C.-H., Bhoo-Pathy, N., Ng, K.-L., et al. (2015) Utility of Pre-Treatment Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio as Prognostic Factors in Breast Cancer. British Journal of Cancer, 113, 150-158.
https://doi.org/10.1038/bjc.2015.183
|
[47]
|
Schmid, P., Adams, S., Rugo, H.S., et al. (2018) Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. The New England Journal of Medicine, 379, 2108-2121. https://doi.org/10.1056/NEJMoa1809615
|
[48]
|
Schmid, P., Salgado, R., Park, Y.H., et al. (2020) Pembrolizumab plus Chemotherapy as Neoadjuvant Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: Results from the Phase 1B Open-Label, Multicohort KEYNOTE-173 Study. Annals of Oncology, 31, 569-581. https://doi.org/10.1016/j.annonc.2020.01.072
|
[49]
|
Schmid, P., Cortes, J., Pusztai, L., et al. (2020) Pembrolizumab for Early Triple-Negative Breast Cancer. The New England Journal of Medicine, 382, 810-821. https://doi.org/10.1056/NEJMoa1910549
|
[50]
|
Martinez, L.M., Robila, V., Clark, N.M., et al. (2019) Regulatory T Cells Control the Switch from in Situ to Invasive Breast Cancer. Frontiers in Immunology, 10, Article 1942. https://doi.org/10.3389/fimmu.2019.01942
|
[51]
|
Xue, L. B., Liu, Y.H., Zhang, B., et al. (2019) Prognostic Role of High Neutrophil-to-Lymphocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Medicine, 98, e13842.
https://doi.org/10.1097/MD.0000000000013842
|
[52]
|
Li, X., Dai, D., Chen, B., et al. (2018) The Value of Neutro-phil-to-Lymphocyte Ratio for Response and Prognostic Effect of Neoadjuvant Chemotherapy in Solid Tumors: A Sys-tematic Review and Meta-Analysis. Journal of Cancer, 9, 861-871. https://doi.org/10.7150/jca.23367
|